Skip to main content

Articles

Page 1 of 61

  1. Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with Type 1 Diabetes (T1D). Early markers of CVD include increased carotid intima-media thickness (CIMT) and pulse ...

    Authors: Michael J. De Biasio, Michelle Furman, Antoine Clarke, Wei Hui, Yesmino Elia, Jerome Baranger, Olivier Villemain, Luc Mertens and Farid H. Mahmud
    Citation: Cardiovascular Diabetology 2024 23:178
  2. Numerous meta-analyses have explored the association between the triglyceride-glucose (TyG) index and diverse health outcomes, yet the comprehensive assessment of the scope, validity, and quality of this evide...

    Authors: Jia-Li Yin, Jing Yang, Xin-Jian Song, Xue Qin, Yu-Jiao Chang, Xing Chen, Fang-Hua Liu, Yi-Zi Li, He-Li Xu, Yi-Fan Wei, Fan Cao, Xue-Li Bai, Lang Wu, Tao Tao, Jian Du, Ting-Ting Gong…
    Citation: Cardiovascular Diabetology 2024 23:177
  3. There is conflicting evidence whether prediabetes is associated with adverse clinical outcomes in patients with chronic coronary syndrome. We aimed to assess the effect of prediabetes in patients with chronic ...

    Authors: Anselm Jorda, Christian Hengstenberg, Irene M. Lang, Alexandra Kautzky-Willer, Jürgen Harreiter, Markus Zeitlinger, Bernd Jilma and Georg Gelbenegger
    Citation: Cardiovascular Diabetology 2024 23:176
  4. Insulin resistance (IR) is the cornerstone of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), pathophysiologically being the key link between MASLD, metabolic disorders, and cardiovascular (C...

    Authors: Alessandra Colantoni, Tommaso Bucci, Nicholas Cocomello, Francesco Angelico, Evaristo Ettorre, Daniele Pastori, Gregory Y.H. Lip, Maria Del Ben and Francesco Baratta
    Citation: Cardiovascular Diabetology 2024 23:175
  5. Growth differentiation factor 15 (GDF15) is a mitokine, the role of which, total or H-specific, in modulating energy metabolism and homeostasis in obesity-related diseases, such as metabolic dysfunction associ...

    Authors: Chrysoula Boutari, Konstantinos Stefanakis, Stamatia Simati, Valentina Guatibonza-García, Laura Valenzuela-Vallejo, Ioanna A. Anastasiou, Margery A. Connelly, Alexander Kokkinos and Christos S. Mantzoros
    Citation: Cardiovascular Diabetology 2024 23:174
  6. Insulin resistance (IR) significantly contributes to cardiovascular disease (CVD) development. Triglyceride glucose (TyG) index and triglyceride glucose-body mass index (TyG-BMI) are recognised as convenient p...

    Authors: Shuijing Zhang, Wenbing Liu, Bin Xu, Shuguang Wang, Zhongyan Du and Wenke Cheng
    Citation: Cardiovascular Diabetology 2024 23:173
  7. Insulin resistance (IR) is linked to both the complexity of coronary artery lesions and the prognosis of acute coronary syndrome (ACS). However, the precise extent of this correlation and its impact on adverse...

    Authors: Qiang Chen, Shiqiang Xiong, Tao Ye, Yanxiang Gao, Jian Wang, Xingliang Li, Yike Li, Caiyan Cui, Hanxiong Liu, Zhen Zhang, Lin Cai and Jingang Zheng
    Citation: Cardiovascular Diabetology 2024 23:172
  8. Although studies have demonstrated the value of the triglyceride–glucose (TyG) index for cardiovascular disease (CVD) and cardiovascular mortality, however, few studies have shown that the TyG index is associa...

    Authors: Chang Liu, Dan Liang, Kun Xiao and Lixin Xie
    Citation: Cardiovascular Diabetology 2024 23:171
  9. Although the TyG index is a reliable predictor of insulin resistance (IR) and cardiovascular disease, its effectiveness in predicting major adverse cardiac events in hospitalized acute coronary syndrome (ACS) ...

    Authors: Wenjie Wang, Jiaxin Yang, Kexin Wang, Jialong Niu, Yixuan Liu and Hailong Ge
    Citation: Cardiovascular Diabetology 2024 23:170
  10. Diabetic heart disease (DHD) is a serious complication in patients with diabetes. Despite numerous studies on the pathogenic mechanisms and therapeutic targets of DHD, effective means of prevention and treatme...

    Authors: Chaoyue Zhang, Yunke Shi, Changzhi Liu, Shivon Mirza Sudesh, Zhao Hu, Pengyang Li, Qi Liu, Yiming Ma, Ao Shi and Hongyan Cai
    Citation: Cardiovascular Diabetology 2024 23:169
  11. The relationship between the triglyceride–glucose (TyG) index and the risk of cardiovascular disease (CVD) in the U.S. population under 65 years of age with diabetes or prediabetes is unknown. The purpose of t...

    Authors: Chang Liu and Dan Liang
    Citation: Cardiovascular Diabetology 2024 23:168
  12. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the proposed name change for non-alcoholic fatty liver disease (NAFLD). This study aimed to investigate the association of cardiovascular dis...

    Authors: Takahiro Nishihara, Toru Miyoshi, Mitsutaka Nakashima, Takashi Miki, Hironobu Toda, Masatoki Yoshida, Keishi Ichikawa, Kazuhiro Osawa and Shinsuke Yuasa
    Citation: Cardiovascular Diabetology 2024 23:167
  13. Studies have shown that RASGRP1 was potently associated with the onset of type 2 diabetes mellitus (T2DM), and RASGRP1 rs7403531 was significantly correlated with islet function in T2DM patients. However, the eff...

    Authors: Jiecan Zhou, Bo Xu, Fazhong He, Yan Shu, Xiaoping Chen, Zhaoqian Liu, Bao Sun and Wei Zhang
    Citation: Cardiovascular Diabetology 2024 23:166
  14. To investigate the contributions of low-grade inflammation measured by C-reactive protein (CRP), hyperglycaemia, and type 2 diabetes to risk of ischemic heart disease (IHD) and cardiovascular disease (CVD) dea...

    Authors: Monica G Rolver, Frida Emanuelsson, Børge G Nordestgaard and Marianne Benn
    Citation: Cardiovascular Diabetology 2024 23:165
  15. Dynamin-related protein 1 (Drp1) is a crucial regulator of mitochondrial dynamics, the overactivation of which can

    Authors: Yuqiong Chen, Su Li, Bo Guan, Xiaopei Yan, Chao Huang, Yingqiang Du, Fan Yang, Nannan Zhang, Yafei Li, Jian Lu, Jiankang Wang, Jun Zhang, Zhangwei Chen, Chao Chen and Xiangqing Kong
    Citation: Cardiovascular Diabetology 2024 23:164
  16. Sepsis is a severe form of systemic inflammatory response syndrome that is caused by infection. Sepsis is characterized by a marked state of stress, which manifests as nonspecific physiological and metabolic c...

    Authors: Fengjuan Yan, Xiehui Chen, Xiaoqing Quan, Lili Wang, Xinyi Wei and Jialiang Zhu
    Citation: Cardiovascular Diabetology 2024 23:163
  17. The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovascular disease. However, the link between TyG-BM...

    Authors: Lyu Lyu, Xinhong Wang, Juan Xu, Zhenzhen Liu, Yanru He, Wenjing Zhu, Lin Lin, Benchuan Hao and Hongbin Liu
    Citation: Cardiovascular Diabetology 2024 23:162
  18. The association between the triglyceride–glucose (TyG) index and subclinical left ventricular (LV) systolic dysfunction in obese patients remains unclear. This study aimed to investigate the relationship betwe...

    Authors: Guang-an Li, Jun Huang, Jing Wang and Li Fan
    Citation: Cardiovascular Diabetology 2024 23:161
  19. In observational and experimental studies, diabetes has been reported as a protective factor for aortic dissection. 3-Hydroxybutyrate, a key constituent of ketone bodies, has been found to favor improvements i...

    Authors: Shi Qiu, Zhen Liu, Wei-Dong Jiang, Jin-Hui Sun, Zeng-Qiang Liu, Xiao-Di Sun, Chun-Ting Wang and Wen Liu
    Citation: Cardiovascular Diabetology 2024 23:159
  20. The association between iron biomarkers and cardiovascular disease risk factors (CVD-RFs) remains unclear. We aimed to (1) evaluate the cross-sectional and longitudinal associations between iron biomarkers (se...

    Authors: Noushin Sadat Ahanchi, Amira Salomé Fischer, Hugo G. Quezada-Pinedo, Farnaz khatami, Michele F. Eisenga, Taulant Muka and Pedro-Marques Vidal
    Citation: Cardiovascular Diabetology 2024 23:158
  21. Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulating metabolites beyond glucose regulation, which could contribute to a reduction in the b...

    Authors: Yanchen Lv, Xin Cheng and Qiang Dong
    Citation: Cardiovascular Diabetology 2024 23:157
  22. Both the triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, and systemic inflammation are predictors of cardiovascular diseases; however, little is known about the coexposures and r...

    Authors: Cancan Cui, Lin Liu, Yitian Qi, Ning Han, Haikun Xu, Zhijia Wang, Xinyun Shang, Tianjiao Han, Yining Zha, Xin Wei and Zhiyuan Wu
    Citation: Cardiovascular Diabetology 2024 23:156
  23. Given the increasing attention to glycemic variability (GV) and its potential implications for cardiovascular outcomes. This study aimed to explore the impact of acute GV on short-term outcomes in Chinese pati...

    Authors: Juan Wang, Lu-lu Wang, Yan-min Yang, Hui-qiong Tan and Jun Zhu
    Citation: Cardiovascular Diabetology 2024 23:155
  24. Insulin resistance (IR) plays an important role in the pathophysiology of cardiovascular disease. Recent studies have shown that diabetes mellitus and impaired lipid metabolism are associated with the severity...

    Authors: Sicheng Zhang, Luyang Gao, Sicong Li, Manqing Luo, Lichuan Chen, Qunying Xi, Zhihui Zhao, Qing Zhao, Tao Yang, Qixian Zeng, Xin Li, Zhihua Huang, Anqi Duan, Yijia Wang, Qin Luo, Yansong Guo…
    Citation: Cardiovascular Diabetology 2024 23:154
  25. Type 2 Diabetes Mellitus (T2DM) presents a significant healthcare challenge, with considerable economic ramifications. While blood glucose management and long-term metabolic target setting for home care and ou...

    Authors: Salvatore Greco, Alessandro Salatiello, Francesco De Motoli, Antonio Giovine, Martina Veronese, Maria Grazia Cupido, Emma Pedarzani, Giorgia Valpiani and Angelina Passaro
    Citation: Cardiovascular Diabetology 2024 23:153
  26. Insulin resistance and chronic kidney disease are both associated with increased coronary artery disease risk. Many formulae estimating glucose disposal rate in type 1 diabetes infer insulin sensitivity from c...

    Authors: Stefan Mutter, Erika B. Parente, Andrzej S. Januszewski, Johan R. Simonsen, Valma Harjutsalo, Per-Henrik Groop, Alicia J. Jenkins and Lena M. Thorn
    Citation: Cardiovascular Diabetology 2024 23:152
  27. The association between the triglyceride-glucose (TyG) index and the likelihood of developing cardiovascular disease (CVD) in the general elderly population in the United States aged 60 and above is not well u...

    Authors: Dan Liang, Chang Liu and Yan Wang
    Citation: Cardiovascular Diabetology 2024 23:151
  28. Vasculopathy is the most common complication of diabetes. Endothelial cells located in the innermost layer of blood vessels are constantly affected by blood flow or vascular components; thus, their mechanosens...

    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Xiang Hu, Yan Liu, Xin Li, Qi Feng, Wei Guo, Nailin Li, Zi Sheng, Shuwen Wang and Jun Peng
    Citation: Cardiovascular Diabetology 2024 23:150
  29. The association between the triglyceride glucose (TyG) index and the risk of early-onset atherosclerotic cardiovascular disease (ASCVD) events or all-cause mortality in young and middle-aged people is not full...

    Authors: Qiqi Hou, Qi Qi, Quanle Han, Jie Yu, Jianmei Wu, Hui Yang, Shuohua Chen, Shouling Wu and Kangbo Li
    Citation: Cardiovascular Diabetology 2024 23:149
  30. Glycemic control, as measured by glycosylated hemoglobin (HbA1c), is an important biomarker to evaluate diabetes severity and is believed to be associated with heart failure development. Type 2 diabetes mellit...

    Authors: Ke Shi, Ge Zhang, Hang Fu, Xue-Ming Li, Yue Gao, Rui Shi, Hua-Yan Xu, Yuan Li, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:148
  31. Cardiovascular disease is the major cause of morbidity and mortality, particularly in type 2 diabetes mellitus (T2DM). Novel markers of insulin resistance and progression of atherosclerosis include the triglyc...

    Authors: Dominika Rokicka, Bartosz Hudzik, Marta Wróbel, Tomasz Stołtny, Dorota Stołtny, Alicja Nowowiejska-Wiewióra, Sonia Rokicka, Mariusz Gąsior and Krzysztof Strojek
    Citation: Cardiovascular Diabetology 2024 23:147
  32. The GLP-1 receptor agonist liraglutide is used to treat hyperglycemia in type 2 diabetes but is also known to induce weight loss, preserve the beta cell and reduce cardiovascular risk. The mechanisms underlyin...

    Authors: Helene Grannes, Thor Ueland, Paola Simeone, Rossella Liani, Maria Teresa Guagnano, Pål Aukrust, Annika E. Michelsen, Kåre Birkeland, Augusto di Castelnuovo, Francesco Cipollone, Agostino Consoli, Bente Halvorsen, Ida Gregersen and Francesca Santilli
    Citation: Cardiovascular Diabetology 2024 23:146
  33. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been suggested to exert cardioprotective effects in patients with heart failure, possibly by improving the metabolism of ketone bodies in the myocardium.

    Authors: Faisal Aziz, Norbert J. Tripolt, Peter N. Pferschy, Hubert Scharnagl, Mahmoud Abdellatif, Abderrahim Oulhaj, Martin Benedikt, Ewald Kolesnik, Dirk von Lewinski and Harald Sourij
    Citation: Cardiovascular Diabetology 2024 23:145
  34. Evidence has shown that women with type 2 diabetes (T2DM) have a higher excess risk for cardiovascular disease (CVD) than men with T2DM. Subjects with either T2DM or prediabetes exhibit myocardial insulin resi...

    Authors: Elena Succurro, Patrizia Vizza, Francesco Cicone, Velia Cassano, Mattia Massimino, Federica Giofrè, Teresa Vanessa Fiorentino, Maria Perticone, Angela Sciacqua, Pietro Hiram Guzzi, Pierangelo Veltri, Francesco Andreozzi, Giuseppe Lucio Cascini and Giorgio Sesti
    Citation: Cardiovascular Diabetology 2024 23:144
  35. Risk assessment for triple-vessel disease (TVD) remain challenging. Stress hyperglycemia represents the regulation of glucose metabolism in response to stress, and stress hyperglycemia ratio (SHR) is recently ...

    Authors: Yu Zhang, Lei Guo, Hao Zhu, Lin Jiang, Lianjun Xu, Dong Wang, Yin Zhang, Xueyan Zhao, Kai Sun, Channa Zhang, Wei Zhao, Rutai Hui, Runlin Gao, Jizheng Wang, Jinqing Yuan, Yunlong Xia…
    Citation: Cardiovascular Diabetology 2024 23:143
  36. This study was designed to assess the associations between emerging cardiometabolic indices—the atherogenic index of plasma (AIP), the stress hyperglycemia ratio (SHR), the triglyceride-glucose (TyG) index, an...

    Authors: Han Yan, Qing Zhou, Yaqiong Wang, Yifan Tu, Yuxin Zhao, Jie Yu, Kuangyang Chen, Yepeng Hu, Qiao Zhou, Wen Zhang and Chao Zheng
    Citation: Cardiovascular Diabetology 2024 23:142
  37. Non-insulin-based insulin resistance (NI-IR) indices have been reported to have an association with prevalent hypertension, however, no cohort studies to date have compared their prediction of hypertension amo...

    Authors: Kun-Zhe Tsai, Chen-Chih Chu, Wei-Chun Huang, Xuemei Sui, Carl J. Lavie and Gen-Min Lin
    Citation: Cardiovascular Diabetology 2024 23:141
  38. Diabetic vascular remodeling is the most important pathological basis of diabetic cardiovascular complications. The accumulation of advanced glycation end products (AGEs) caused by elevated blood glucose promo...

    Authors: Xinyue Huang, Jiayan Guo, Anqi Ning, Naijin Zhang and Yingxian Sun
    Citation: Cardiovascular Diabetology 2024 23:140
  39. Diabetic cardiomyopathy (DCM) poses a growing health threat, elevating heart failure risk in diabetic individuals. Understanding DCM is crucial, with fibroblasts and endothelial cells playing pivotal roles in ...

    Authors: Qiang Su, Wanzhong Huang, Yuan Huang, Rixin Dai, Chen Chang, Qiu-Yan Li, Hao Liu, Zhenhao Li, Yuxiang Zhao, Qiang Wu and Di-Guang Pan
    Citation: Cardiovascular Diabetology 2024 23:139
  40. Neutral cholesterol ester hydrolase 1 (NCEH1) plays a critical role in the regulation of cholesterol ester metabolism. Deficiency of NCHE1 accelerated atherosclerotic lesion formation in mice. Nonetheless, the...

    Authors: Hai-Jian Sun, Zhang-Rong Ni, Yao Liu, Xiao Fu, Shi-Yi Liu, Jin-Yi Hu, Qing-Yi Sun, Yu-Chao Li, Xiao-Hui Hou, Ji-Ru Zhang, Xue-Xue Zhu and Qing-Bo Lu
    Citation: Cardiovascular Diabetology 2024 23:138
  41. As the retina is suggested to mirror the brain, we hypothesized that diabetic retinopathy and macular edema are indicative of stroke risk in type 1 diabetes and sought to assess this association in individuals...

    Authors: Marika I Eriksson, Kustaa Hietala, Paula Summanen, Valma Harjutsalo, Jukka Putaala, Anni Ylinen, Stefanie Hägg-Holmberg, Per-Henrik Groop and Lena M Thorn
    Citation: Cardiovascular Diabetology 2024 23:136
  42. The triglyceride-glucose (TyG) index and blood pressure (BP) are correlated and serve as risk factors for cardiovascular disease (CVD). The potential impact of BP status on the association between the TyG inde...

    Authors: Weida Qiu, Anping Cai, Liwen Li and Yingqing Feng
    Citation: Cardiovascular Diabetology 2024 23:135
  43. Triglyceride-glucose (TyG) index has been determined to play a role in the onset of metabolic syndrome (MetS). Whether the TyG index and TyG with the combination of obesity indicators are associated with the c...

    Authors: Xiaoyuan Wei, Yu Min, Ge Song, Xin Ye and Lei Liu
    Citation: Cardiovascular Diabetology 2024 23:134
  44. Metabolic syndrome (MetS) can increase the risk of morbidity and mortality of cardiovascular disease and obstructive coronary artery disease (OCAD), which usually have a poor prognosis. This study aimed to exp...

    Authors: Chen-Yan Min, Yue Gao, Yi-Ning Jiang, Ying-Kun Guo, Ke Shi, Zhi‑Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2024 23:133
  45. Diabetes mellitus (DM) is thought to be closely related to arterial stenotic or occlusive disease caused by atherosclerosis. However, there is still no definitive clinical evidence to confirm that patients wit...

    Authors: Xiaolei Sun, Cheng Zhang, Yarong Ma, Yanzheng He, Xiaodong Zhang and Jianbo Wu
    Citation: Cardiovascular Diabetology 2024 23:132
  46. Serum uric acid (SUA) is an important pathogenetic and prognostic factor for heart failure (HF). Gender differences are apparent in HF. Furthermore, gender differences also exist in the association between SUA...

    Authors: Kang Fu, Congyi Cheng, Cong Su, Junlin Teng, Lei Qiao, Jie Xiao, Xiaoping Ji, Huixia Lu and Wenqiang Chen
    Citation: Cardiovascular Diabetology 2024 23:131
  47. Fasting glucose (FG) demonstrates dynamic fluctuations over time and is associated with cardiovascular outcomes, yet current research is limited by small sample sizes and relies solely on baseline glycemic lev...

    Authors: Mianli Xiao, Markku A. Malmi Jr., Douglas D. Schocken, Janice C. Zgibor and Amy C. Alman
    Citation: Cardiovascular Diabetology 2024 23:130
  48. Type 2 diabetes (T2D) and peripheral artery disease (PAD) are recognized as independent risk factors contributing to excess mortality. Contemporary observational studies exploring the associations of risk fact...

    Authors: Tarik Avdic, Hanne K. Carlsen, Aidin Rawshani, Soffia Gudbjörnsdottir, Zacharias Mandalenakis and Björn Eliasson
    Citation: Cardiovascular Diabetology 2024 23:127

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions